Jones Financial Companies’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$318M Buy
2,659,381
+1,779,735
+202% +$205M 0.15% 65
2025
Q4
$92.6M Buy
879,646
+41,110
+5% +$3.86M 0.06% 108
2025
Q3
$66.5M Sell
838,536
-15,360
-2% -$1.27M 0.05% 128
2025
Q2
$67.6M Buy
853,896
+55,988
+7% +$4.45M 0.05% 108
2025
Q1
$71.3M Buy
797,908
+191,441
+32% +$17.9M 0.06% 85
2024
Q4
$60.3M Buy
606,467
+152,177
+33% +$15.7M 0.06% 79
2024
Q3
$51.6M Buy
454,290
+154,817
+52% +$18.4M 0.05% 73
2024
Q2
$37.1M Buy
299,473
+98,604
+49% +$12.7M 0.04% 70
2024
Q1
$26.5M Buy
200,869
+23,485
+13% +$2.89M 0.04% 70
2023
Q4
$19.3M Buy
177,384
+6,158
+4% +$639K 0.03% 72
2023
Q3
$17.6M Sell
171,226
-1,724
-1% -$186K 0.03% 68
2023
Q2
$20M Sell
172,950
-5,377
-3% -$611K 0.03% 68
2023
Q1
$19M Sell
178,327
-3,663
-2% -$395K 0.03% 68
2022
Q4
$20.2M Buy
181,990
+3,152
+2% +$322K 0.04% 65
2022
Q3
$15.4M Sell
178,838
-908
-0.5% -$81.1K 0.03% 66
2022
Q2
$16.4M Sell
179,746
-7,355
-4% -$652K 0.03% 63
2022
Q1
$15.4M Buy
187,101
+5,438
+3% +$429K 0.02% 74
2021
Q4
$13.9M Buy
181,663
+2,568
+1% +$205K 0.02% 81
2021
Q3
$13.5M Buy
179,095
+317
+0.2% +$24.1K 0.02% 81
2021
Q2
$13.9M Sell
178,778
-8,238
-4% -$613K 0.02% 79
2021
Q1
$13.8M Buy
187,016
+797
+0.4% +$58.8K 0.02% 77
2020
Q4
$14.5M Buy
186,219
+4,886
+3% +$374K 0.03% 71
2020
Q3
$14.4M Buy
181,333
+3,017
+2% +$236K 0.03% 67
2020
Q2
$13.2M Sell
178,316
-8,486
-5% -$639K 0.03% 68
2020
Q1
$13.7M Buy
186,802
+3,380
+2% +$266K 0.03% 59
2019
Q4
$15.9M Buy
183,422
+3,873
+2% +$318K 0.03% 58
2019
Q3
$14.4M Sell
179,549
-3,250
-2% -$260K 0.03% 58
2019
Q2
$14.6M Buy
182,799
+6,642
+4% +$509K 0.03% 58
2019
Q1
$14M Sell
176,157
-2,635
-1% -$197K 0.03% 58
2018
Q4
$13M Sell
178,792
-18,181
-9% -$1.28M 0.03% 56
2018
Q3
$13.3M Sell
196,973
-376
-0.2% -$24K 0.03% 58
2018
Q2
$11.4M Buy
197,349
+3,239
+2% +$183K 0.03% 63
2018
Q1
$10.1M Buy
194,110
+12,745
+7% +$688K 0.02% 65
2017
Q4
$9.74M Buy
181,365
+21,751
+14% +$1.21M 0.02% 69
2017
Q3
$9.75M Sell
159,614
-18,025
-10% -$1.09M 0.03% 68
2017
Q2
$10.9M Sell
177,639
-16,670
-9% -$1.01M 0.03% 61
2017
Q1
$11.8M Sell
194,309
-7,945
-4% -$482K 0.04% 57
2016
Q4
$11.4M Sell
202,254
-5,663
-3% -$331K 0.04% 56
2016
Q3
$12.4M Sell
207,917
-19,438
-9% -$1.14M 0.05% 47
2016
Q2
$12.5M Buy
227,355
+1,423
+0.6% +$75.7K 0.05% 43
2016
Q1
$11.4M Buy
225,932
+5,986
+3% +$293K 0.07% 40
2015
Q4
$11.1M Buy
219,946
+2,329
+1% +$117K 0.07% 39
2015
Q3
$10.3M Buy
217,617
+10,035
+5% +$533K 0.07% 41
2015
Q2
$11.3M Sell
207,582
-2,255
-1% -$126K 0.07% 39
2015
Q1
$11.5M Buy
209,837
+14,838
+8% +$840K 0.08% 38
2014
Q4
$10.6M Buy
194,999
+4,322
+2% +$241K 0.07% 40
2014
Q3
$10.8M Buy
190,677
+12,541
+7% +$704K 0.08% 35
2014
Q2
$9.83M Buy
178,136
+1,317
+0.7% +$71.8K 0.07% 38
2014
Q1
$9.58M Buy
176,819
+2,059
+1% +$107K 0.08% 40
2013
Q4
$8.35M Buy
174,760
+11,801
+7% +$539K 0.07% 42
2013
Q3
$7.4M Buy
162,959
+16,524
+11% +$754K 0.07% 43
2013
Q2
$6.49M Buy
+146,435
New +$6.54M 0.07% 42

Other funds holding MRK

Jones Financial Companies's MRK Position: Q1 2026 in Review

Jones Financial Companies increased its Merck (MRK) stake by 202% in Q1 2026, buying an estimated $205M and bringing the position to 2,659,381 shares worth $318M. The position accounts for 0.15% of the portfolio, ranked #65.

Jones Financial Companies first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Jones Financial Companies held 2,659,381 shares of Merck worth $318M as of Q1 2026.
  • Jones Financial Companies bought 1,779,735 Merck shares in Q1 2026, an estimated $205M.
  • Merck made up 0.15% of Jones Financial Companies's portfolio in Q1 2026, its #65 holding.
  • Jones Financial Companies first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.